{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:54:38Z","timestamp":1777290878118,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1053\/j.seminoncol.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T04:49:47Z","timestamp":1441687787000},"page":"909-914","source":"Crossref","is-referenced-by-count":14,"title":["Parathyroid Hormone-Related Peptide\u2013Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates"],"prefix":"10.1053","volume":"42","author":[{"given":"Teresa Anne","family":"Mills","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlana","family":"Orloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Domingo-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cotzia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth C.","family":"Birbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossitza","family":"Draganova-Tacheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.","family":"Martinez Cantarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Tuluc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Martinez-Outschoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2015.09.006_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.seminoncol.2013.04.016","article-title":"Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome?","volume":"40","author":"Martinez-Outschoorn","year":"2013","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1245\/s10434-006-9262-y","article-title":"Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction","volume":"14","author":"Lagarde","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib3","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib4","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrc3915","article-title":"Caveolae and signalling in cancer","volume":"15","author":"Martinez-Outschoorn","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0962-8924(01)82148-6","article-title":"Cellular senescence as a tumor-suppressor mechanism","volume":"11","author":"Campisi","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib8","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2014.55.1432","article-title":"Biology of cancer and aging: a complex association with cellular senescence","volume":"32","author":"Falandry","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrc3773","article-title":"Inside and out: the activities of senescence in cancer","volume":"14","author":"Perez-Mancera","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth","volume":"25","author":"Martinez-Outschoorn","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib12","doi-asserted-by":"crossref","first-page":"h2723","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00008390-200110000-00006","article-title":"Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates","volume":"11","author":"des Grottes","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","article-title":"Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients","volume":"112","author":"Ralston","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MED.0b013e32834b4401","article-title":"Mechanisms and treatment of hypercalcemia of malignancy","volume":"18","author":"Clines","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib16","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0025-6196(12)62163-6","article-title":"Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions","volume":"65","author":"Kao","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1677\/erc.0.0100403","article-title":"Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels","volume":"10","author":"Takahashi","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1681\/ASN.2007090981","article-title":"PTH-related peptide (PTHrP) in hypercalcemia","volume":"19","author":"Mundy","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib20","first-page":"912","article-title":"A thymoma as a cause of true ectopic hyperparathyroidism","volume":"79","author":"Rizzoli","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000017960","article-title":"Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein","volume":"197","author":"Matsui","year":"1998","journal-title":"Dermatology"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000023188","article-title":"Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma","volume":"49","author":"Yeung","year":"1998","journal-title":"Horm Res"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib24","doi-asserted-by":"crossref","first-page":"C1230","DOI":"10.1152\/ajpcell.2000.279.4.C1230","article-title":"Expression and regulation of parathyroid hormone-related peptide in normal and malignant melanocytes","volume":"279","author":"El Abdaimi","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2133.2003.05171.x","article-title":"Widespread expression of parathyroid hormone-related peptide in melanocytic cells","volume":"148","author":"Kageshita","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib27","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1210\/jc.2012-2142","article-title":"Parathyroid hormone-related protein: an update","volume":"97","author":"Wysolmerski","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.273.5275.663","article-title":"PTH\/PTHrP receptor in early development and Indian hedgehog-regulated bone growth","volume":"273","author":"Lanske","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/physrev.1996.76.1.127","article-title":"Defining the roles of parathyroid hormone-related protein in normal physiology","volume":"76","author":"Philbrick","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib30","doi-asserted-by":"crossref","first-page":"20309","DOI":"10.1073\/pnas.0805690105","article-title":"Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein","volume":"105","author":"Miao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib31","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1096\/fj.09-147033","article-title":"The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice","volume":"24","author":"Toribio","year":"2010","journal-title":"Faseb J"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ijc.1425","article-title":"Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen","volume":"94","author":"Iguchi","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib33","first-page":"2665","article-title":"Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy","volume":"24","author":"Onuma","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1078-0432.CCR-06-1487","article-title":"Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides","volume":"13","author":"Hashimoto","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/JCO.2005.01.128","article-title":"Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma","volume":"23","author":"Sanderson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1470-2045(09)70334-1","article-title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","volume":"11","author":"Wolchok","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2015.09.006_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-13-0499","article-title":"Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution","volume":"21","author":"Ryder","year":"2014","journal-title":"Endocr Relat Cancer"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775415001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775415001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T07:43:43Z","timestamp":1567151023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775415001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0093775415001712"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2015.09.006","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}